Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Future Medicinal Chemistry|January 10, 2015
Cancer cell metabolism as new targets for novel designed therapiesIgor Marín de Mas, Esther Aguilar, Anusha Jayaraman, et al.
Biology|July 28, 2026
Immune-Metabolic Profiling Reveals Functional Heterogeneity Within Colorectal Cancer Consensus Molecular SubtypesSergio Madurga, David López-Blanco, Carles Foguet, et al.
Molecular Systems Biology|April 2, 2025
Metabolic reaction fluxes as amplifiers and buffers of risk alleles for coronary artery diseaseCarles Foguet, Xilin Jiang, Scott C Ritchie, et al.
Cancers|January 27, 2021
Cysteine and Folate Metabolism Are Targetable Vulnerabilities of Metastatic Colorectal CancerJosep Tarragó-Celada, Carles Foguet, Míriam Tarrado-Castellarnau, et al.
Frontiers in Immunology|September 19, 2022
A novel gene signature unveils three distinct immune-metabolic rewiring patterns conserved across diverse tumor types and associated with outcomesLeire Pedrosa, Carles Foguet, Helena Oliveres, et al.
Oncogene|July 22, 2025
Glutaminase as a metabolic target of choice to counter acquired resistance to Palbociclib by colorectal cancer cellsMíriam Tarrado-Castellarnau, Carles Foguet, Josep Tarragó-Celada, et al.
Nature Communications|November 29, 2022
Genetically personalised organ-specific metabolic models in health and diseaseCarles Foguet, Yu Xu, Scott C Ritchie, et al.
Frontiers in Immunology|September 7, 2023
Immunometabolic actions of trabectedin and lurbinectedin on human macrophages: relevance for their anti-tumor activityAdrián Povo-Retana, Marco Fariñas, Rodrigo Landauro-Vera, et al.
Cancer Immunology, Immunotherapy : CII|September 9, 2022
A Phase I-II multicenter trial with Avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients; GEMCAD 1602 studyMarta Español-Rego, Carlos Fernández-Martos, Elena Elez, et al.
Medrxiv : the Preprint Server for Health Sciences|September 4, 2024
Integrated clinical risk prediction of type 2 diabetes with a multifactorial polygenic risk scoreScott C Ritchie, Henry J Taylor, Yujian Liang, et al.
Pageof 3